ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA RECURRENT

This adverse event was reported 26 times

ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ROMIDEPSIN 1 0.0006
1 VORINOSTAT 1 0.0005
2 VINCRISTINE SULFATE 9 0.0003
3 CARMUSTINE 1 0.0002
4 DOXORUBICIN 15 0.0002
5 ETOPOSIDE 9 0.0001
6 DOXORUBICIN HYDROCHLORIDE 4 0.0001
7 ALEMTUZUMAB 2 0.0001
8 BRENTUXIMAB VEDOTIN 1 0.0001
9 CYCLOPHOSPHAMIDE FOR INJECTION 15 0.0001
See all drugs enriched for association with ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA RECURRENT